Famiglie GNAO1 hosted the first European GNAO1 conference in Rome, Italy on 16 November 2019. The goal of this conference was to engage the medical, research, rehabilitation and health policy community in Italy and Europe to:

  • Begin the foundations of a strong center of innovative GNAO1 research and practice in the European Union
  • Facilitate global initiatives with intercontinental project teams.

Conference highlights:

  • Presentations by clinicians, researchers and therapists from Italy, The Netherlands, Germany, UK and Switzerland
  • Attendance by 20+ families from 9 countries
  • Patronage of the European Parliament
  • Medal of Recognition from the President of the Republic of Italy

A special thanks, once more, to the National Roman Museum – Thermal Baths of Diocletian for their hospitality and the special reception dedicated to our children.

Presentations and videos

Massimiliano Tomassi
Famiglie GNAO1 Association

Welcome and presentation of the Famiglie GNAO1 Association

Domenica Taruscio
National Centre for Rare Diseases, National Institute of Health

Rare Diseases: National and International Contexts

Vincenzo Leuzzi
Sapienza University of Rome

Characteristics of GNAO1 Movement Disorders and Paroxysms

Renzo Guerrini
Meyer Children’s Hospital of Florence

Epileptic and Dyskinetic Encephalopathies

Enza Maria Valente
University of Pavia

Mutational Spectrum and Pathogenic Mechanisms

Domenica Battaglia, Daniela Ricci
Agostino Gemelli University Hospital Foundation

Cognitive Development and Neuro-visual Function in Children with GNAO1 Mutations

Alessandro Capuano
Bambino Gesù Children’s Hospital of Rome

Pharmacological Treatment of Dyskinetic and Dystonic States in Domestic and Hospital Settings

Miryam Carecchio
University of Padua

Pharmacological Treatments and Long-term Clinical Outcomes

Anne Koy
University of Cologne

Effects of DBS in patients with GNAO1

Jean-Pierre Lin
Evelina London Children’s Hospital

Long-term and short-term outcomes of DBS for GNAO1 dystonia-dyskinesia in childhood: what can families expect?

Frank Baas
Leiden University Medical Centre

Gene identification and studies in neurodevelopmental disorders

Vladimir Katanaev
University of Geneva

GNAO1/Gαo: from fundamental research on the functions of the major neuronal G protein to development of novel approaches to the treatment of pediatric encephalopathies

Raffaela Amantis
Leonarda Vaccari Institute of Rome

Augmentative and Alternative Communication (AAC): Strategies and Tools for Engagement and Autonomy

Maria Teresa Giannini
Sapienza University of Rome

Neuromotor Rehabilitation in Children with GNAO1

Eva Broekhuizen
Stichting GNAO1 NL

Presentation of the “Stichting GNAO1” Dutch Foundation